Prosecution Insights
Last updated: November 04, 2026

Prime Bio Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Prime Bio Inc. currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single matter is being handled by 1 distinct examiner. The prosecution is located within 1 distinct art unit, reflecting a very specific technical focus for the company's current patent activity. This alignment ensures that the application is being reviewed within a specialized group dedicated to its specific biological field.

GRASER, JENNIFER E is the busiest examiner for the portfolio, managing the 1 pending office action. As there is only 1 pending office action in total, GRASER, JENNIFER E is the sole examiner responsible for the company's current pending matters. This 1 pending action represents the entirety of the portfolio's active office actions, making her review critical to the company's immediate success.

The concentration in 1 distinct art unit and the involvement of only 1 distinct examiner simplifies the current prosecution landscape for the company. GRASER, JENNIFER E's role is central, as she oversees the only 1 pending office action. The biotechnology focus is contained within this single examiner's review of the 1 total pending action, allowing for a highly focused response strategy.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GRASER, JENNIFER E 1 76.9% +23.2%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19017741 TETANUS VACCINE PLATFORM FOR EMBEDDING COVID-19 VACCINE GRASER, JENNIFER E —

Top Art Units

Art UnitApps
1645 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19017741 TETANUS VACCINE PLATFORM FOR EMBEDDING COVID-19 VACCINE GRASER, JENNIFER E 1645 §103§112DP Non-Final OA — Pending Jan 12, 2025

Managing Prime Bio Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Prime Bio Inc. have?

Prime Bio Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Prime Bio Inc. applications?

Jennifer E Graser has the most, with 1 of Prime Bio Inc.'s pending office actions.

What technology area are Prime Bio Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month